Study S000537

A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of XW003 Injections in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

ClinicalTrials.gov record

Registration

Registration: NCT07387094
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: RECRUITING
Enrollment: 140
Start: 2026-02-09
Primary completion: 2027-12-16
Lead sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Conditions: OSA - Obstructive Sleep Apnea; Obesity
Interventions: DRUG:XW003 injection; DRUG:placebo with matching volume
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Change from baseline in Apnea-Hypopnea Index (AHI) [at week 48]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.